MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2024 Evaluate
With no major difference for the quarter endedDecember 2023 , the total revenue stood at Rs. 6939.00  millions.Modest increase of 5.19% in the Net Profit was reported from. 1309.00 millions to Rs. 1377.00  millions.Operating profit surged to 1994.00 millions from the corresponding previous quarter of 1869.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202312 202212 % Var
Sales 6939.00 6719.00 3.27 28511.00 27701.00 2.92 28511.00 27701.00 2.92
Other Income 120.00 200.00 -40.00 653.00 715.00 -8.67 653.00 715.00 -8.67
PBIDT 1994.00 1869.00 6.69 8693.00 7759.00 12.04 8693.00 7759.00 12.04
Interest 4.00 4.00 0.00 17.00 17.00 0.00 17.00 17.00 0.00
PBDT 1990.00 2004.00 -0.70 8854.00 9062.00 -2.30 8854.00 9062.00 -2.30
Depreciation 102.00 100.00 2.00 396.00 419.00 -5.49 396.00 419.00 -5.49
PBT 1888.00 1904.00 -0.84 8458.00 8643.00 -2.14 8458.00 8643.00 -2.14
TAX 511.00 595.00 -14.12 2426.00 2437.00 -0.45 2426.00 2437.00 -0.45
Deferred Tax 15.00 -35.00 -142.86 -7.00 -15.00 -53.33 -7.00 -15.00 -53.33
PAT 1377.00 1309.00 5.19 6032.00 6206.00 -2.80 6032.00 6206.00 -2.80
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 28.74 27.82 3.31 30.49 28.01 8.85 30.49 28.01 8.85
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..